{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:30:59Z","timestamp":1791228659742,"version":"4.1.0"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1097\/pas.0000000000000445","type":"journal-article","created":{"date-parts":[[2015,5,30]],"date-time":"2015-05-30T12:53:09Z","timestamp":1432990389000},"page":"1093-1101","source":"Crossref","is-referenced-by-count":32,"title":["Skin Involvement of Mantle Cell Lymphoma May Mimic Primary Cutaneous Diffuse Large B-cell Lymphoma, Leg Type"],"prefix":"10.1097","volume":"39","author":[{"given":"Ulrike","family":"Wehkamp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"Pott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Unterhalt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karoline","family":"Koch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Weichenthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfram","family":"Klapper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilske","family":"Oschlies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-10-20210131","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1365-2141.2005.05716.x","article-title":". Histopathology, cell proliferation indices and clinical outcome in 304 patients with mantle cell lymphoma (MCL): a clinicopathological study from the European MCL Network.","volume":"131","author":"Tiemann","year":"2005","journal-title":"Br J Haematol"},{"key":"R3-10-20210131","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.3324\/haematol.2014.107938","article-title":". Early lymphoid lesions: conceptual, diagnostic and clinical challenges.","volume":"99","author":"Ganapathi","year":"2014","journal-title":"Haematologica"},{"key":"R4-10-20210131","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1182\/blood.V89.6.2067","article-title":". Mantle cell lymphoma: a clinicopathologic study of 80 cases.","volume":"89","author":"Argatoff","year":"1997","journal-title":"Blood"},{"key":"R5-10-20210131","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1309\/508R-YBWW-Y0AC-82GA","article-title":". Value of interphase FISH for the diagnosis of t(11:14)(q13;q32) on skin lesions of mantle cell lymphoma.","volume":"118","author":"Dubus","year":"2002","journal-title":"Am J Clin Pathol"},{"key":"R6-10-20210131","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1097\/00000478-200210000-00008","article-title":". Mantle cell lymphoma involving skin: cutaneous lesions may be the first manifestation of disease and tumors often have blastoid cytologic features.","volume":"26","author":"Sen","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"R7-10-20210131","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s12308-009-0036-x","article-title":". Ki-67 as a prognostic marker in mantle cell lymphoma-consensus guidelines of the pathology panel of the European MCL Network.","volume":"2","author":"Klapper","year":"2009","journal-title":"J Hematopathol"},{"key":"R8-10-20210131","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00292-006-0878-2","article-title":"Follicular and mantle cell lymphoma. Extranodal involvement of primarily nodal indolent B-cell lymphomas.","volume":"28","author":"Klapper","year":"2007","journal-title":"Pathologe"},{"key":"R9-10-20210131","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1097\/DAD.0b013e31828de73a","article-title":". Mantle cell lymphoma of blastoid variant with skin lesion and rapid progression: a case report and literature review.","volume":"35","author":"Cao","year":"2013","journal-title":"Am J Dermatopathol"},{"key":"R10-10-20210131","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1097\/DAD.0b013e31828bc7ac","article-title":". Primary cutaneous mantle cell lymphoma of the leg with blastoid morphology and aberrant immunophenotype: a diagnostic challenge.","volume":"36","author":"Cesinaro","year":"2014","journal-title":"Am J Dermatopathol"},{"key":"R12-10-20210131","first-page":"394596","article-title":". Primary cutaneous mantle cell lymphoma: a case report.","volume":"2013","author":"Mazzuoccolo","year":"2013","journal-title":"Case Rep Dermatol Med"},{"key":"R13-10-20210131","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1097\/DAD.0b013e3182a12e88","article-title":"Blastoid mantle cell lymphoma with cutaneous involvement and aberrant immunophenotype.","volume":"36","author":"Phelps","year":"2014","journal-title":"Am J Dermatopathol"},{"key":"R14-10-20210131","doi-asserted-by":"crossref","first-page":"551","DOI":"10.3324\/haematol.11267","article-title":". Minimal residual disease detection in mantle cell lymphoma: methods and significance of four-color flow cytometry compared to consensus IGH-polymerase chain reaction at initial staging and for follow-up examinations.","volume":"93","author":"Bottcher","year":"2008","journal-title":"Haematologica"},{"issue":"suppl 3","key":"R15-10-20210131","doi-asserted-by":"crossref","first-page":"iii83","DOI":"10.1093\/annonc\/mdu264","article-title":". Newly diagnosed and relapsed mantle cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-updagger.","volume":"25","author":"Dreyling","year":"2014","journal-title":"Ann Oncol"},{"key":"R17-10-20210131","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1200\/JCO.2013.52.2466","article-title":". Confirmation of the mantle-cell lymphoma International Prognostic Index in randomized trials of the European Mantle-Cell Lymphoma Network.","volume":"32","author":"Hoster","year":"2014","journal-title":"J Clin Oncol"},{"key":"R18-10-20210131","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1200\/JCO.2006.08.4251","article-title":". Specific secondary genetic alterations in mantle cell lymphoma provide prognostic information independent of the gene expression-based proliferation signature.","volume":"25","author":"Salaverria","year":"2007","journal-title":"J Clin Oncol"},{"key":"R19-10-20210131","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1182\/blood-2014-04-569566","article-title":". SOX11 promotes tumor angiogenesis through transcriptional regulation of PDGFA in mantle cell lymphoma.","volume":"124","author":"Palomero","year":"2014","journal-title":"Blood"},{"key":"R20-10-20210131","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.leukres.2011.06.004","article-title":". The expression of IgM is helpful in the differentiation of primary cutaneous diffuse large B cell lymphoma and follicle center lymphoma.","volume":"35","author":"Demirkesen","year":"2011","journal-title":"Leuk Res"},{"key":"R21-10-20210131","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1097\/PAS.0b013e3181e5060a","article-title":". IgM expression on paraffin sections distinguishes primary cutaneous large B-cell lymphoma, leg type from primary cutaneous follicle center lymphoma.","volume":"34","author":"Koens","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"R22-10-20210131","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1001\/archderm.143.9.1144","article-title":". Primary cutaneous diffuse large B-cell lymphoma, leg type: clinicopathologic features and prognostic analysis in 60 cases.","volume":"143","author":"Grange","year":"2007","journal-title":"Arch Dermatol"},{"key":"R23-10-20210131","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.jaad.2006.12.026","article-title":". New prognostic relevant factors in primary cutaneous diffuse large B-cell lymphomas.","volume":"56","author":"Hallermann","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"R24-10-20210131","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1182\/blood-2005-03-1175","article-title":". Primary cutaneous large B-cell lymphomas: clinicopathologic features, classification, and prognostic factors in a large series of patients.","volume":"106","author":"Kodama","year":"2005","journal-title":"Blood"},{"key":"R25-10-20210131","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1111\/j.1365-2133.2003.05649.x","article-title":". Bcl-6 and CD10 expression in cutaneous B-cell lymphoma: further support for a follicle centre cell origin and differential diagnostic significance.","volume":"149","author":"Hoefnagel","year":"2003","journal-title":"Br J Dermatol"},{"key":"R26-10-20210131","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/00000478-200103000-00004","article-title":". Primary cutaneous large B-cell lymphoma: the relation between morphology, clinical presentation, immunohistochemical markers, and survival.","volume":"25","author":"Fernandez-Vazquez","year":"2001","journal-title":"Am J Surg Pathol"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000000445","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T04:45:02Z","timestamp":1620967502000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000478-201508000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":23,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000000445","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]}}}